Dr. Agarwal's Health Care Current Share Price | Dr. Agarwal's Health Care Stock Screener
AGARWALEYE
Hospitals
Dr. Agarwal's Health Care Current Stock Price Today
Live Share Price NSE
₹500.45
▲
0.30 (0.06%)
Live Share Price BSE
₹499.80
▼
-0.05 (-0.01%)
As of September 18, 2026, the live Dr. Agarwal's Health Care share price (NSE: AGARWALEYE) is ₹500.45 on NSE and ₹499.80 on BSE, up 0.06% from the previous close, with shares trading between ₹495.20 and ₹503.00 in today's trading session, and a 52-week range of ₹406.55–₹560.70.
Browse AGARWALEYE income statement to support your investment research.
Use the Dr. Agarwal's Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dr. Agarwal's Health Care Market Cap
₹15,914.13 Cr.
AGARWALEYE P/E Ratio (TTM)
86.82
Dr. Agarwal's Health Care P/B Ratio
7.91
EPS (TTM)
₹4.21
Dividend Yield
-
Debt to Equity
0.60
AGARWALEYE 52 Week High
₹560.70
Dr. Agarwal's Health Care 52 Week Low
₹406.55
Operating Margin
28.00%
Profit Margin
8.87%
AGARWALEYE Revenue (TTM)
₹620.00
EBITDA
₹177.00
Net Income
₹55.00
Total Assets
₹3,942.00
Total Equity
₹2,026.00
Dr. Agarwal's Health Care Current Share Price Chart
Track the current Dr. Agarwal's Health Care share price and stock price with an interactive chart. Analyse AGARWALEYE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Dr. Agarwal's Health Care stock quote in one place.
Dr. Agarwal's Health Care Company Profile - Fundamental Screener
Screen Dr. Agarwal's Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AGARWALEYE shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE943P01029
Dr. Agarwal's Health Care Balance Sheet Screener
Screen AGARWALEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 3,942 | 3,672 | 2,753 | 1,825 | 1,026 | 787 | 752 |
| Current Assets | 573 | 794 | 759 | 310 | 228 | 155 | 146 |
| Fixed Assets | 2,378 | 2,523 | 1,746 | 1,293 | 702 | 575 | 551 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,361 | 1,267 | 974 | 865 | 586 | 438 | 339 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 2,026 | 1,927 | 1,380 | 659 | 234 | 199 | 267 |
| Share Capital | 32 | 32 | 9 | 8 | 7 | 7 | 7 |
| Reserves & Surplus | 1,994 | 1,835 | 1,330 | 622 | 206 | 177 | 242 |
Dr. Agarwal's Health Care Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Agarwal's Health Care income statement and profit fundamentals.
Analyze AGARWALEYE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr. Agarwal's Health Care share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 620 | 578 | 540 | 507 | 501 | 476 | 443 | 429 | 410 | 369 | 345 |
| Expenses | 444 | 403 | 386 | 363 | 360 | 332 | 316 | 310 | 300 | 241 | 244 |
| EBITDA | 177 | 175 | 155 | 144 | 141 | 144 | 128 | 119 | 110 | 128 | 101 |
| Operating Profit % | 28.00% | 29.00% | 27.00% | 27.00% | 26.00% | 28.00% | 27.00% | 26.00% | 26.00% | 31.00% | 27.00% |
| Depreciation | 78 | 77 | 69 | 68 | 63 | 60 | 58 | 57 | 56 | 47 | 43 |
| Interest | 23 | 22 | 21 | 23 | 25 | 25 | 28 | 28 | 27 | 27 | 22 |
| Profit Before Tax | 75 | 77 | 65 | 54 | 54 | 59 | 41 | 33 | 27 | 54 | 36 |
| Tax | 20 | 27 | 21 | 17 | 16 | 16 | 13 | 12 | 9 | 13 | 13 |
| Net Profit | 55 | 50 | 44 | 37 | 38 | 43 | 28 | 21 | 18 | 41 | 23 |
| EPS | 1.43 | 1.25 | 1.07 | 0.94 | 0.95 | 1.04 | 0.73 | 0.45 | 0.43 | 1.39 | 1.94 |
Dr. Agarwal's Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AGARWALEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 360 | 346 | 233 | 164 | 99 | 103 |
| Investing Activities | -750 | -914 | -509 | -155 | -46 | -85 |
| Financing Activities | 382 | 553 | 303 | 35 | -37 | -74 |
| Net Cash Flow | -8 | -15 | 27 | 44 | 17 | -56 |
Dr. Agarwal's Health Care Shareholding Pattern Screener
See Dr. Agarwal's Health Care shareholding pattern with promoter, FII, and DII holdings.
Check Dr. Agarwal's Health Care promoter holding and ownership changes for AGARWALEYE on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Jan | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.36% | 32.34% | 37.73% | 32.45% | 32.45% | 32.42% | 32.42% | 32.39% |
| FII Holding | 57.94% | 57.96% | 0.00% | 56.97% | 60.62% | 59.26% | 58.13% | 58.06% |
| DII Holding | 7.83% | 7.72% | 0.00% | 5.10% | 5.21% | 6.44% | 7.92% | 7.78% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 1.68% | 1.81% | 0.00% | 4.79% | 1.61% | 1.74% | 1.41% | 1.62% |
| Other Holding | 0.19% | 0.17% | 62.27% | 0.69% | 0.11% | 0.14% | 0.11% | 0.15% |
| Shareholder Count | 43,538 | 42,492 | 43 | 217,289 | 68,696 | 63,021 | 48,168 | 46,554 |
Dr. Agarwal's Health Care Share Dividend Screener - Share Yield Analysis
Check Dr. Agarwal's Health Care dividend history with payout and yield data.
View Dr. Agarwal's Health Care dividend details including ex-dates and amounts for AGARWALEYE stock.
Dr. Agarwal's Health Care Stock Index Membership
See which indices include Dr. Agarwal's Health Care stock.
Check AGARWALEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSEIPO
NIFTY IPO
Dr. Agarwal's Health Care Market Events Screener - Corporate Actions
Get Dr. Agarwal's Health Care corporate actions including splits, bonuses, and buybacks.
Check Dr. Agarwal's Health Care stock events that may affect AGARWALEYE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-21 | 2026-09-21 | Annual General Meeting | NA | 2.08% |
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | 1.63% |
| 2026-07-02 | 2026-07-02 | Extraordinary General Meeting | NA | -3.02% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 2.95% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -1.33% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -5.93% |
| 2025-09-24 | 2025-09-24 | Annual General Meeting | NA | 6.16% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.07% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -6.56% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 11.55% |
Dr. Agarwal's Health Care Competitors Screener - Peer Comparison
Screen AGARWALEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,294 | 58.59 | 25,420 | 15.58% | 2,003 | 45.96 |
| Max Healthcare Institute | 100,244 | 69.29 | 8,536 | 18.82% | 1,442 | 51.73 |
| Fortis Healthcare | 66,444 | 62.57 | 9,179 | 16.93% | 1,064 | 35.63 |
| Aster DM Quality Care | 64,613 | 183.40 | 4,769 | 11.25% | 427 | 34.68 |
| Narayana Hrudayalaya | 38,724 | 46.73 | 7,996 | 43.43% | 811 | 50.05 |
| Global Health | 38,128 | 70.47 | 4,509 | 19.56% | 554 | 47.68 |
| Krishna Institute of Medical Sciences | 32,208 | 166.06 | 3,931 | 28.16% | 242 | 44.81 |
| Dr. Agarwal's Health Care | 15,914 | 86.82 | 2,080 | 18.39% | 168 | 46.24 |
| Rainbow Childrens Medicare | 14,764 | 50.50 | 1,747 | 11.49% | 282 | 48.72 |
| Park Medi World | 12,057 | 40.63 | 1,711 | 19.99% | 274 | 45.84 |
Dr. Agarwal's Health Care Company Announcements - News Screener
Screen AGARWALEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-28 | Reg. 34 (1) Annual Report. | - |
| 2026-08-28 | Sixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21 2026 | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-04 | Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-08-04 | Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-28 | Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026 | - |